Tagliamonte Silvia, Oliviero Veronica, Vitaglione Paola
Department of Agricultural Sciences, University of Naples Federico II, Portici, Italy.
Nutr Rev. 2025 Feb 1;83(2):369-381. doi: 10.1093/nutrit/nuae008.
Bitter taste is an aversive taste because it is unconsciously associated with toxic compounds. However, a considerable variability in bitter sensitivity exists in those who have the genetic polymorphism for bitter taste receptors (TAS2Rs). Besides the oral cavity, TAS2Rs are present in many body tissues, including the gastrointestinal tract; therefore, they are crucial players both in the gustatory/hedonic system and in the homeostatic system, triggering numerous biological responses, including adipogenesis, carcinogenesis, or immunity. Bitter-tasting compounds are widely distributed in plant and animal foods and belong to many chemical classes. In this study, the evidence was reviewed on bitter peptides, considering the food sources, their formation in food under different processing and storage conditions and in the gastrointestinal tract during digestion, as well as their biological activities. Bitterness associated with peptides is due to the presence of hydrophobic amino acids in the C-terminus. The current literature mainly explores the enzymes and hydrolysis conditions, with the aim of reducing the formation of bitter peptides in hydrolysate preparation or food. Few studies highlight the bioactivity (namely, antihypertensive, antidiabetic, antioxidant, or immunity boosting), besides the bitterness. However, encapsulation of bitter peptides has been tentatively used to develop antihypertensive and antidiabetic supplements. In the era of personalized nutrition and precision medicine, the evidence available suggests the opportunity to use bitter bioactive peptides as functional ingredients in food. Such types of food may modulate a plethora of physiological mechanisms by targeting TAS2Rs in the gastrointestinal tract, thus modulating appetite sensations or gastrointestinal motility and discomfort according to individual nutritional needs and goals. More studies are needed to optimize the technological strategies to target TAS2Rs by bitter bioactive peptides, improve their stability in food, and validate the biological efficacy through well-designed in vivo studies.
苦味是一种令人厌恶的味道,因为它在无意识中与有毒化合物相关联。然而,对于具有苦味受体(TAS2Rs)基因多态性的人来说,苦味敏感性存在相当大的差异。除口腔外,TAS2Rs还存在于许多身体组织中,包括胃肠道;因此,它们在味觉/享乐系统和稳态系统中都是关键参与者,触发众多生物反应,包括脂肪生成、致癌作用或免疫反应。苦味化合物广泛分布于植物和动物食品中,属于许多化学类别。在本研究中,我们综述了关于苦味肽的证据,考虑了其食物来源、在不同加工和储存条件下以及消化过程中在胃肠道内食物中的形成,以及它们的生物活性。与肽相关的苦味是由于C末端存在疏水性氨基酸。当前文献主要探讨酶和水解条件,目的是在水解产物制备或食品中减少苦味肽的形成。除了苦味外,很少有研究强调其生物活性(即抗高血压、抗糖尿病、抗氧化或增强免疫力)。然而,苦味肽的包封已被尝试用于开发抗高血压和抗糖尿病补充剂。在个性化营养和精准医学时代,现有证据表明有机会将苦味生物活性肽用作食品中的功能成分。这类食品可能通过靶向胃肠道中的TAS2Rs来调节多种生理机制,从而根据个体营养需求和目标调节食欲、胃肠道蠕动和不适。需要更多研究来优化通过苦味生物活性肽靶向TAS2Rs的技术策略,提高其在食品中的稳定性,并通过精心设计的体内研究验证其生物学功效。